The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2000

Filed:

Nov. 09, 1998
Applicant:
Inventors:

William E Klunk, Pittsburgh, PA (US);

Jay W Pettegrew, Pittsburgh, PA (US);

Chester A Mathis, Jr, Pittsburgh, PA (US);

Assignee:

University of Pittsburgh, Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N / ;
U.S. Cl.
CPC ...
5142305 ; 514248 ; 514296 ; 514309 ; 514364 ; 514371 ; 514381 ; 514417 ; 514493 ; 514534 ; 514568 ; 424-111 ; 544 64 ; 544 94 ; 544225 ; 544237 ; 546100 ; 546103 ; 546123 ; 546241 ; 546478 ; 546480 ; 548101 ; 548143 ; 562475 ; 556 87 ;
Abstract

Amyloid binding compounds which are non-azo derivatives of Chrysamine G, pharmaceutical compositions containing, and methods using such compounds to identify Alzheimer's brain in vivo and to diagnose other pathological conditions characterized by amyloidosis, such as Down's Syndrome are described. Pharmaceutical compositions containing non-azo derivatives of Chrysamine G and methods using such compositions to prevent cell degeneration and amyloid-induced toxicity in amyloidosis associated conditions are also described. Methods using non-azo Chrysamine G derivatives to stain or detect amyloid deposits in biopsy or post-mortem tissue are also described. Methods using non-azo Chrysamine G derivatives to quantify amyloid deposits in homogenates of biopsy and post-mortem tissue are also described.


Find Patent Forward Citations

Loading…